SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-016654
Filing Date
2023-05-02
Accepted
2023-05-02 16:02:32
Documents
78
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q srpt-20230331.htm   iXBRL 10-Q 3711821
2 EX-31.1 srpt-ex31_1.htm EX-31 15229
3 EX-31.2 srpt-ex31_2.htm EX-31 15336
4 EX-32.1 srpt-ex32_1.htm EX-32 10902
5 EX-32.2 srpt-ex32_2.htm EX-32 10717
  Complete submission text file 0000950170-23-016654.txt   12120535

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srpt-20230331_pre.xml EX-101.PRE 381599
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srpt-20230331_cal.xml EX-101.CAL 71435
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srpt-20230331.xsd EX-101.SCH 72532
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srpt-20230331_lab.xml EX-101.LAB 498231
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srpt-20230331_def.xml EX-101.DEF 228375
72 EXTRACTED XBRL INSTANCE DOCUMENT srpt-20230331_htm.xml XML 2507177
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 23878790
SIC: 2834 Pharmaceutical Preparations